Health Care Technology
Company Overview of Medytox Solutions, Inc.
Medytox Solutions, Inc. offers clinical laboratory blood and urine testing services to physicians, clinics, and rehabilitation facilities in the United States. The company operates in two segments, Clinical Laboratory Operations and Medical Support Solutions. It focuses on providing urine and blood drug toxicology and pain medication monitoring programs. The company’s turn-key urine drug testing program allows physicians to monitor and treat patients. It also offers medical support services primarily to its clinical laboratories, as well as to its third party customers. The company was formerly known as Casino Players, Inc. and changed its name to Medytox Solutions, Inc. in 2011. Medytox Sol...
400 South Australian Avenue
West Palm Beach, FL 33401
Founded in 2005
Key Executives for Medytox Solutions, Inc.
Chief Executive Officer and Director
Chief Executive Officer of the Medytox Laboratories
Total Annual Compensation: $373.5K
Vice President of Sales & Marketing
Total Annual Compensation: $353.0K
Compensation as of Fiscal Year 2014.
Medytox Solutions, Inc. Key Developments
Medytox Solutions, Inc. Appoints Michael L. Goldberg and Robert Lee as Directors
Aug 7 15
Medytox Solutions, Inc. has appointed Michael L. Goldberg and Robert Lee as directors to the Board of Directors at the AGM held on August 6, 2015.
Medytox Solutions, Inc., Annual General Meeting, Aug 06, 2015
Jul 10 15
Medytox Solutions, Inc., Annual General Meeting, Aug 06, 2015., at 11:00 US Eastern Standard Time. Location: West Palm Beach Marriott, 1001 Okeechobee Boulevard. Agenda: To elect five members to board of directors to hold office until next annual meeting of stockholders or until their successors are duly elected and qualified; to approve an advisory (non-binding) resolution on the company’s executive compensation; to approve an advisory (non-binding) resolution on the frequency of stockholder voting on the company’s executive compensation; and to transact such other business as may properly come before the annual meeting and any adjournments or postponements thereof.
Medytox Solutions, Inc. Appoints Jeffrey L. Wadman as Interim Chief Financial Officer
May 1 15
Medytox Solutions, Inc. announced that Jeffrey L. Wadman has assumed the position of interim chief financial officer. Mr. Wadman was previously the corporate controller for Medytox Solutions, where he liaised with senior management and investor relations teams on budgeting and forecasting, SEC regulations and reporting, and technical accounting. In his new role, Mr. Wadman will continue to focus on accounting and reporting, budget management, and strategic planning with Medytox's senior leadership. Mr. Wadman is assuming the role of interim chief financial officer after Mr. Jace Simmons, former chief financial officer of Medytox Solutions, Inc., and the company agreed to seek a new CFO from the healthcare industry. Mr. Wadman has a long experience as a senior finance executive, especially in the healthcare industry. Prior to joining Medytox in 2014, from 2008, he was the Senior Vice President and Chief Accounting Officer of Oxbow Carbon LLC.
Similar Private Companies By Industry
Recent Private Companies Transactions